nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CBR1—prostate cancer	0.584	1	CbGaD
Tetrabenazine—CBR1—Doxorubicin—prostate cancer	0.151	0.667	CbGbCtD
Tetrabenazine—CYP2D6—Bicalutamide—prostate cancer	0.0381	0.168	CbGbCtD
Tetrabenazine—CYP2D6—Abiraterone—prostate cancer	0.0315	0.139	CbGbCtD
Tetrabenazine—CYP2D6—Doxorubicin—prostate cancer	0.00583	0.0257	CbGbCtD
Tetrabenazine—Donepezil—ACHE—prostate cancer	0.00189	0.783	CrCbGaD
Tetrabenazine—CBR1—prostate gland—prostate cancer	0.00188	0.137	CbGeAlD
Tetrabenazine—SLC18A2—prostate gland—prostate cancer	0.00162	0.117	CbGeAlD
Tetrabenazine—CBR1—seminal vesicle—prostate cancer	0.00159	0.116	CbGeAlD
Tetrabenazine—CYP2D6—urine—prostate cancer	0.00151	0.109	CbGeAlD
Tetrabenazine—CBR1—renal system—prostate cancer	0.00128	0.0931	CbGeAlD
Tetrabenazine—CBR1—urethra—prostate cancer	0.00126	0.0915	CbGeAlD
Tetrabenazine—CBR1—bone marrow—prostate cancer	0.000971	0.0704	CbGeAlD
Tetrabenazine—CBR1—testis—prostate cancer	0.00083	0.0602	CbGeAlD
Tetrabenazine—SLC18A2—testis—prostate cancer	0.000714	0.0518	CbGeAlD
Tetrabenazine—CBR1—lymph node—prostate cancer	0.000602	0.0436	CbGeAlD
Tetrabenazine—Donepezil—CYP3A4—prostate cancer	0.000523	0.217	CrCbGaD
Tetrabenazine—SLC18A2—lymph node—prostate cancer	0.000517	0.0375	CbGeAlD
Tetrabenazine—DRD2—testis—prostate cancer	0.000397	0.0288	CbGeAlD
Tetrabenazine—CYP2D6—renal system—prostate cancer	0.000369	0.0268	CbGeAlD
Tetrabenazine—CYP2D6—testis—prostate cancer	0.000238	0.0173	CbGeAlD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000126	0.00119	CcSEcCtD
Tetrabenazine—Dysuria—Capecitabine—prostate cancer	0.000125	0.00118	CcSEcCtD
Tetrabenazine—Leukopenia—Mitoxantrone—prostate cancer	0.000125	0.00117	CcSEcCtD
Tetrabenazine—Dry mouth—Estradiol—prostate cancer	0.000124	0.00117	CcSEcCtD
Tetrabenazine—Eye disorder—Etoposide—prostate cancer	0.000124	0.00117	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Capecitabine—prostate cancer	0.000124	0.00117	CcSEcCtD
Tetrabenazine—Ecchymosis—Doxorubicin—prostate cancer	0.000124	0.00117	CcSEcCtD
Tetrabenazine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000124	0.00116	CcSEcCtD
Tetrabenazine—Cardiac disorder—Etoposide—prostate cancer	0.000123	0.00116	CcSEcCtD
Tetrabenazine—Confusional state—Estradiol—prostate cancer	0.000123	0.00116	CcSEcCtD
Tetrabenazine—Body temperature increased—Goserelin—prostate cancer	0.000122	0.00114	CcSEcCtD
Tetrabenazine—Angiopathy—Etoposide—prostate cancer	0.000121	0.00114	CcSEcCtD
Tetrabenazine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.00012	0.00113	CcSEcCtD
Tetrabenazine—Nervous system disorder—Estradiol—prostate cancer	0.00012	0.00113	CcSEcCtD
Tetrabenazine—Depression—Capecitabine—prostate cancer	0.000119	0.00112	CcSEcCtD
Tetrabenazine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000119	0.00112	CcSEcCtD
Tetrabenazine—Skin disorder—Estradiol—prostate cancer	0.000118	0.00111	CcSEcCtD
Tetrabenazine—Anxiety—Mitoxantrone—prostate cancer	0.000118	0.00111	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Estradiol—prostate cancer	0.000118	0.00111	CcSEcCtD
Tetrabenazine—Headache—Ethinyl Estradiol—prostate cancer	0.000117	0.0011	CcSEcCtD
Tetrabenazine—Confusional state—Mitoxantrone—prostate cancer	0.000115	0.00108	CcSEcCtD
Tetrabenazine—Nausea—Ethinyl Estradiol—prostate cancer	0.000111	0.00104	CcSEcCtD
Tetrabenazine—Asthenia—Goserelin—prostate cancer	0.00011	0.00104	CcSEcCtD
Tetrabenazine—Skin disorder—Mitoxantrone—prostate cancer	0.00011	0.00104	CcSEcCtD
Tetrabenazine—Insomnia—Estradiol—prostate cancer	0.00011	0.00104	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.00011	0.00103	CcSEcCtD
Tetrabenazine—Asthenia—Conjugated Estrogens—prostate cancer	0.000109	0.00103	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Docetaxel—prostate cancer	0.000109	0.00103	CcSEcCtD
Tetrabenazine—Bradycardia—Capecitabine—prostate cancer	0.000109	0.00103	CcSEcCtD
Tetrabenazine—Dyspnoea—Estradiol—prostate cancer	0.000109	0.00102	CcSEcCtD
Tetrabenazine—Somnolence—Estradiol—prostate cancer	0.000108	0.00102	CcSEcCtD
Tetrabenazine—Urethral disorder—Docetaxel—prostate cancer	0.000108	0.00102	CcSEcCtD
Tetrabenazine—Osteoarthritis—Epirubicin—prostate cancer	0.000108	0.00101	CcSEcCtD
Tetrabenazine—Hypotension—Mitoxantrone—prostate cancer	0.000106	0.000999	CcSEcCtD
Tetrabenazine—Decreased appetite—Estradiol—prostate cancer	0.000106	0.000998	CcSEcCtD
Tetrabenazine—Depression—Prednisone—prostate cancer	0.000106	0.000997	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Capecitabine—prostate cancer	0.000106	0.000995	CcSEcCtD
Tetrabenazine—Diarrhoea—Goserelin—prostate cancer	0.000105	0.00099	CcSEcCtD
Tetrabenazine—Fatigue—Estradiol—prostate cancer	0.000105	0.000989	CcSEcCtD
Tetrabenazine—Urethral disorder—Capecitabine—prostate cancer	0.000105	0.000987	CcSEcCtD
Tetrabenazine—Constipation—Estradiol—prostate cancer	0.000104	0.000981	CcSEcCtD
Tetrabenazine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000104	0.000981	CcSEcCtD
Tetrabenazine—Leukopenia—Etoposide—prostate cancer	0.000104	0.000975	CcSEcCtD
Tetrabenazine—Eye disorder—Docetaxel—prostate cancer	0.000103	0.000972	CcSEcCtD
Tetrabenazine—Cardiac disorder—Docetaxel—prostate cancer	0.000103	0.000966	CcSEcCtD
Tetrabenazine—Dizziness—Goserelin—prostate cancer	0.000102	0.000957	CcSEcCtD
Tetrabenazine—Ataxia—Epirubicin—prostate cancer	0.000101	0.000954	CcSEcCtD
Tetrabenazine—Dyspnoea—Mitoxantrone—prostate cancer	0.000101	0.000953	CcSEcCtD
Tetrabenazine—Somnolence—Mitoxantrone—prostate cancer	0.000101	0.000951	CcSEcCtD
Tetrabenazine—Dizziness—Conjugated Estrogens—prostate cancer	0.000101	0.000948	CcSEcCtD
Tetrabenazine—Feeling abnormal—Estradiol—prostate cancer	0.000101	0.000946	CcSEcCtD
Tetrabenazine—Angiopathy—Docetaxel—prostate cancer	0.0001	0.000944	CcSEcCtD
Tetrabenazine—Eye disorder—Capecitabine—prostate cancer	0.0001	0.000941	CcSEcCtD
Tetrabenazine—Osteoarthritis—Doxorubicin—prostate cancer	9.98e-05	0.000939	CcSEcCtD
Tetrabenazine—Cardiac disorder—Capecitabine—prostate cancer	9.94e-05	0.000935	CcSEcCtD
Tetrabenazine—Decreased appetite—Mitoxantrone—prostate cancer	9.88e-05	0.000929	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Epirubicin—prostate cancer	9.85e-05	0.000926	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Epirubicin—prostate cancer	9.85e-05	0.000926	CcSEcCtD
Tetrabenazine—Fatigue—Mitoxantrone—prostate cancer	9.8e-05	0.000922	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	9.79e-05	0.000921	CcSEcCtD
Tetrabenazine—Vomiting—Goserelin—prostate cancer	9.78e-05	0.00092	CcSEcCtD
Tetrabenazine—Breast disorder—Epirubicin—prostate cancer	9.74e-05	0.000917	CcSEcCtD
Tetrabenazine—Constipation—Mitoxantrone—prostate cancer	9.72e-05	0.000914	CcSEcCtD
Tetrabenazine—Angiopathy—Capecitabine—prostate cancer	9.71e-05	0.000914	CcSEcCtD
Tetrabenazine—Bradycardia—Prednisone—prostate cancer	9.71e-05	0.000913	CcSEcCtD
Tetrabenazine—Vomiting—Conjugated Estrogens—prostate cancer	9.69e-05	0.000912	CcSEcCtD
Tetrabenazine—Mental disorder—Docetaxel—prostate cancer	9.69e-05	0.000911	CcSEcCtD
Tetrabenazine—Body temperature increased—Estradiol—prostate cancer	9.64e-05	0.000907	CcSEcCtD
Tetrabenazine—Headache—Goserelin—prostate cancer	9.64e-05	0.000907	CcSEcCtD
Tetrabenazine—Headache—Conjugated Estrogens—prostate cancer	9.55e-05	0.000898	CcSEcCtD
Tetrabenazine—Confusional state—Etoposide—prostate cancer	9.53e-05	0.000897	CcSEcCtD
Tetrabenazine—Ataxia—Doxorubicin—prostate cancer	9.38e-05	0.000882	CcSEcCtD
Tetrabenazine—Mental disorder—Capecitabine—prostate cancer	9.38e-05	0.000882	CcSEcCtD
Tetrabenazine—Feeling abnormal—Mitoxantrone—prostate cancer	9.37e-05	0.000881	CcSEcCtD
Tetrabenazine—Dysphagia—Epirubicin—prostate cancer	9.32e-05	0.000877	CcSEcCtD
Tetrabenazine—Skin disorder—Etoposide—prostate cancer	9.18e-05	0.000864	CcSEcCtD
Tetrabenazine—Nausea—Goserelin—prostate cancer	9.14e-05	0.00086	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Etoposide—prostate cancer	9.14e-05	0.00086	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Doxorubicin—prostate cancer	9.11e-05	0.000857	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Doxorubicin—prostate cancer	9.11e-05	0.000857	CcSEcCtD
Tetrabenazine—Nausea—Conjugated Estrogens—prostate cancer	9.05e-05	0.000852	CcSEcCtD
Tetrabenazine—Breast disorder—Doxorubicin—prostate cancer	9.02e-05	0.000848	CcSEcCtD
Tetrabenazine—Body temperature increased—Mitoxantrone—prostate cancer	8.98e-05	0.000845	CcSEcCtD
Tetrabenazine—Bronchitis—Epirubicin—prostate cancer	8.96e-05	0.000843	CcSEcCtD
Tetrabenazine—Eye disorder—Prednisone—prostate cancer	8.91e-05	0.000838	CcSEcCtD
Tetrabenazine—Hypotension—Etoposide—prostate cancer	8.83e-05	0.000831	CcSEcCtD
Tetrabenazine—Asthenia—Estradiol—prostate cancer	8.75e-05	0.000823	CcSEcCtD
Tetrabenazine—Tremor—Capecitabine—prostate cancer	8.73e-05	0.000821	CcSEcCtD
Tetrabenazine—Dysuria—Epirubicin—prostate cancer	8.71e-05	0.00082	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Epirubicin—prostate cancer	8.66e-05	0.000815	CcSEcCtD
Tetrabenazine—Angiopathy—Prednisone—prostate cancer	8.65e-05	0.000814	CcSEcCtD
Tetrabenazine—Dysphagia—Doxorubicin—prostate cancer	8.62e-05	0.000811	CcSEcCtD
Tetrabenazine—Leukopenia—Docetaxel—prostate cancer	8.62e-05	0.000811	CcSEcCtD
Tetrabenazine—Dyspnoea—Etoposide—prostate cancer	8.43e-05	0.000793	CcSEcCtD
Tetrabenazine—Somnolence—Etoposide—prostate cancer	8.4e-05	0.000791	CcSEcCtD
Tetrabenazine—Mental disorder—Prednisone—prostate cancer	8.36e-05	0.000786	CcSEcCtD
Tetrabenazine—Diarrhoea—Estradiol—prostate cancer	8.35e-05	0.000785	CcSEcCtD
Tetrabenazine—Leukopenia—Capecitabine—prostate cancer	8.34e-05	0.000785	CcSEcCtD
Tetrabenazine—Drowsiness—Epirubicin—prostate cancer	8.31e-05	0.000782	CcSEcCtD
Tetrabenazine—Bronchitis—Doxorubicin—prostate cancer	8.29e-05	0.00078	CcSEcCtD
Tetrabenazine—Decreased appetite—Etoposide—prostate cancer	8.22e-05	0.000773	CcSEcCtD
Tetrabenazine—Asthenia—Mitoxantrone—prostate cancer	8.15e-05	0.000767	CcSEcCtD
Tetrabenazine—Fatigue—Etoposide—prostate cancer	8.15e-05	0.000767	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	8.14e-05	0.000766	CcSEcCtD
Tetrabenazine—Constipation—Etoposide—prostate cancer	8.08e-05	0.000761	CcSEcCtD
Tetrabenazine—Dizziness—Estradiol—prostate cancer	8.07e-05	0.000759	CcSEcCtD
Tetrabenazine—Dysuria—Doxorubicin—prostate cancer	8.06e-05	0.000759	CcSEcCtD
Tetrabenazine—Dry mouth—Docetaxel—prostate cancer	8.02e-05	0.000754	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Doxorubicin—prostate cancer	8.01e-05	0.000754	CcSEcCtD
Tetrabenazine—Sweating—Epirubicin—prostate cancer	7.97e-05	0.000749	CcSEcCtD
Tetrabenazine—Confusional state—Docetaxel—prostate cancer	7.92e-05	0.000745	CcSEcCtD
Tetrabenazine—Anxiety—Capecitabine—prostate cancer	7.91e-05	0.000744	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	7.88e-05	0.000741	CcSEcCtD
Tetrabenazine—Feeling abnormal—Etoposide—prostate cancer	7.79e-05	0.000733	CcSEcCtD
Tetrabenazine—Diarrhoea—Mitoxantrone—prostate cancer	7.78e-05	0.000732	CcSEcCtD
Tetrabenazine—Dry mouth—Capecitabine—prostate cancer	7.76e-05	0.00073	CcSEcCtD
Tetrabenazine—Vomiting—Estradiol—prostate cancer	7.76e-05	0.00073	CcSEcCtD
Tetrabenazine—Nervous system disorder—Docetaxel—prostate cancer	7.7e-05	0.000725	CcSEcCtD
Tetrabenazine—Drowsiness—Doxorubicin—prostate cancer	7.69e-05	0.000723	CcSEcCtD
Tetrabenazine—Confusional state—Capecitabine—prostate cancer	7.67e-05	0.000722	CcSEcCtD
Tetrabenazine—Headache—Estradiol—prostate cancer	7.64e-05	0.000719	CcSEcCtD
Tetrabenazine—Skin disorder—Docetaxel—prostate cancer	7.63e-05	0.000718	CcSEcCtD
Tetrabenazine—Agitation—Prednisone—prostate cancer	7.63e-05	0.000718	CcSEcCtD
Tetrabenazine—Bradycardia—Epirubicin—prostate cancer	7.59e-05	0.000714	CcSEcCtD
Tetrabenazine—Body temperature increased—Etoposide—prostate cancer	7.47e-05	0.000703	CcSEcCtD
Tetrabenazine—Nervous system disorder—Capecitabine—prostate cancer	7.46e-05	0.000702	CcSEcCtD
Tetrabenazine—Skin disorder—Capecitabine—prostate cancer	7.39e-05	0.000695	CcSEcCtD
Tetrabenazine—Sweating—Doxorubicin—prostate cancer	7.37e-05	0.000693	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Epirubicin—prostate cancer	7.37e-05	0.000693	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Capecitabine—prostate cancer	7.35e-05	0.000692	CcSEcCtD
Tetrabenazine—Hypotension—Docetaxel—prostate cancer	7.34e-05	0.000691	CcSEcCtD
Tetrabenazine—Urethral disorder—Epirubicin—prostate cancer	7.31e-05	0.000688	CcSEcCtD
Tetrabenazine—Nausea—Estradiol—prostate cancer	7.25e-05	0.000682	CcSEcCtD
Tetrabenazine—Vomiting—Mitoxantrone—prostate cancer	7.23e-05	0.00068	CcSEcCtD
Tetrabenazine—Headache—Mitoxantrone—prostate cancer	7.12e-05	0.00067	CcSEcCtD
Tetrabenazine—Hypotension—Capecitabine—prostate cancer	7.11e-05	0.000669	CcSEcCtD
Tetrabenazine—Insomnia—Docetaxel—prostate cancer	7.11e-05	0.000668	CcSEcCtD
Tetrabenazine—Anxiety—Prednisone—prostate cancer	7.04e-05	0.000663	CcSEcCtD
Tetrabenazine—Bradycardia—Doxorubicin—prostate cancer	7.03e-05	0.000661	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	7.02e-05	0.00066	CcSEcCtD
Tetrabenazine—Dyspnoea—Docetaxel—prostate cancer	7e-05	0.000659	CcSEcCtD
Tetrabenazine—Somnolence—Docetaxel—prostate cancer	6.98e-05	0.000657	CcSEcCtD
Tetrabenazine—Eye disorder—Epirubicin—prostate cancer	6.97e-05	0.000656	CcSEcCtD
Tetrabenazine—Cardiac disorder—Epirubicin—prostate cancer	6.92e-05	0.000651	CcSEcCtD
Tetrabenazine—Insomnia—Capecitabine—prostate cancer	6.88e-05	0.000647	CcSEcCtD
Tetrabenazine—Decreased appetite—Docetaxel—prostate cancer	6.83e-05	0.000643	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Doxorubicin—prostate cancer	6.82e-05	0.000641	CcSEcCtD
Tetrabenazine—Asthenia—Etoposide—prostate cancer	6.78e-05	0.000638	CcSEcCtD
Tetrabenazine—Dyspnoea—Capecitabine—prostate cancer	6.78e-05	0.000638	CcSEcCtD
Tetrabenazine—Fatigue—Docetaxel—prostate cancer	6.77e-05	0.000637	CcSEcCtD
Tetrabenazine—Angiopathy—Epirubicin—prostate cancer	6.77e-05	0.000637	CcSEcCtD
Tetrabenazine—Urethral disorder—Doxorubicin—prostate cancer	6.77e-05	0.000636	CcSEcCtD
Tetrabenazine—Nausea—Mitoxantrone—prostate cancer	6.75e-05	0.000635	CcSEcCtD
Tetrabenazine—Constipation—Docetaxel—prostate cancer	6.72e-05	0.000632	CcSEcCtD
Tetrabenazine—Nervous system disorder—Prednisone—prostate cancer	6.64e-05	0.000625	CcSEcCtD
Tetrabenazine—Decreased appetite—Capecitabine—prostate cancer	6.61e-05	0.000622	CcSEcCtD
Tetrabenazine—Skin disorder—Prednisone—prostate cancer	6.58e-05	0.000619	CcSEcCtD
Tetrabenazine—Fatigue—Capecitabine—prostate cancer	6.56e-05	0.000617	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Prednisone—prostate cancer	6.55e-05	0.000616	CcSEcCtD
Tetrabenazine—Mental disorder—Epirubicin—prostate cancer	6.53e-05	0.000615	CcSEcCtD
Tetrabenazine—Constipation—Capecitabine—prostate cancer	6.5e-05	0.000612	CcSEcCtD
Tetrabenazine—Feeling abnormal—Docetaxel—prostate cancer	6.47e-05	0.000609	CcSEcCtD
Tetrabenazine—Diarrhoea—Etoposide—prostate cancer	6.47e-05	0.000609	CcSEcCtD
Tetrabenazine—Eye disorder—Doxorubicin—prostate cancer	6.45e-05	0.000607	CcSEcCtD
Tetrabenazine—Cardiac disorder—Doxorubicin—prostate cancer	6.41e-05	0.000603	CcSEcCtD
Tetrabenazine—Tension—Epirubicin—prostate cancer	6.37e-05	0.000599	CcSEcCtD
Tetrabenazine—Nervousness—Epirubicin—prostate cancer	6.31e-05	0.000593	CcSEcCtD
Tetrabenazine—Feeling abnormal—Capecitabine—prostate cancer	6.27e-05	0.00059	CcSEcCtD
Tetrabenazine—Angiopathy—Doxorubicin—prostate cancer	6.26e-05	0.000589	CcSEcCtD
Tetrabenazine—Dizziness—Etoposide—prostate cancer	6.25e-05	0.000588	CcSEcCtD
Tetrabenazine—Body temperature increased—Docetaxel—prostate cancer	6.21e-05	0.000584	CcSEcCtD
Tetrabenazine—Insomnia—Prednisone—prostate cancer	6.13e-05	0.000577	CcSEcCtD
Tetrabenazine—Mental disorder—Doxorubicin—prostate cancer	6.05e-05	0.000569	CcSEcCtD
Tetrabenazine—Body temperature increased—Capecitabine—prostate cancer	6.01e-05	0.000566	CcSEcCtD
Tetrabenazine—Vomiting—Etoposide—prostate cancer	6.01e-05	0.000565	CcSEcCtD
Tetrabenazine—Agitation—Epirubicin—prostate cancer	5.97e-05	0.000561	CcSEcCtD
Tetrabenazine—Headache—Etoposide—prostate cancer	5.92e-05	0.000557	CcSEcCtD
Tetrabenazine—Tension—Doxorubicin—prostate cancer	5.9e-05	0.000555	CcSEcCtD
Tetrabenazine—Decreased appetite—Prednisone—prostate cancer	5.89e-05	0.000554	CcSEcCtD
Tetrabenazine—Fatigue—Prednisone—prostate cancer	5.84e-05	0.00055	CcSEcCtD
Tetrabenazine—Nervousness—Doxorubicin—prostate cancer	5.84e-05	0.000549	CcSEcCtD
Tetrabenazine—Leukopenia—Epirubicin—prostate cancer	5.81e-05	0.000547	CcSEcCtD
Tetrabenazine—Constipation—Prednisone—prostate cancer	5.79e-05	0.000545	CcSEcCtD
Tetrabenazine—Asthenia—Docetaxel—prostate cancer	5.64e-05	0.00053	CcSEcCtD
Tetrabenazine—Nausea—Etoposide—prostate cancer	5.62e-05	0.000528	CcSEcCtD
Tetrabenazine—Feeling abnormal—Prednisone—prostate cancer	5.58e-05	0.000525	CcSEcCtD
Tetrabenazine—Agitation—Doxorubicin—prostate cancer	5.52e-05	0.000519	CcSEcCtD
Tetrabenazine—Anxiety—Epirubicin—prostate cancer	5.51e-05	0.000518	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.49e-05	0.000516	CcSEcCtD
Tetrabenazine—Asthenia—Capecitabine—prostate cancer	5.46e-05	0.000513	CcSEcCtD
Tetrabenazine—Dry mouth—Epirubicin—prostate cancer	5.41e-05	0.000509	CcSEcCtD
Tetrabenazine—Leukopenia—Doxorubicin—prostate cancer	5.38e-05	0.000506	CcSEcCtD
Tetrabenazine—Diarrhoea—Docetaxel—prostate cancer	5.38e-05	0.000506	CcSEcCtD
Tetrabenazine—Body temperature increased—Prednisone—prostate cancer	5.36e-05	0.000504	CcSEcCtD
Tetrabenazine—Confusional state—Epirubicin—prostate cancer	5.34e-05	0.000503	CcSEcCtD
Tetrabenazine—Diarrhoea—Capecitabine—prostate cancer	5.2e-05	0.00049	CcSEcCtD
Tetrabenazine—Nervous system disorder—Epirubicin—prostate cancer	5.2e-05	0.000489	CcSEcCtD
Tetrabenazine—Dizziness—Docetaxel—prostate cancer	5.2e-05	0.000489	CcSEcCtD
Tetrabenazine—Skin disorder—Epirubicin—prostate cancer	5.15e-05	0.000484	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Epirubicin—prostate cancer	5.12e-05	0.000482	CcSEcCtD
Tetrabenazine—Anxiety—Doxorubicin—prostate cancer	5.1e-05	0.00048	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.08e-05	0.000478	CcSEcCtD
Tetrabenazine—Dizziness—Capecitabine—prostate cancer	5.03e-05	0.000473	CcSEcCtD
Tetrabenazine—Dry mouth—Doxorubicin—prostate cancer	5e-05	0.000471	CcSEcCtD
Tetrabenazine—Vomiting—Docetaxel—prostate cancer	5e-05	0.00047	CcSEcCtD
Tetrabenazine—Hypotension—Epirubicin—prostate cancer	4.95e-05	0.000466	CcSEcCtD
Tetrabenazine—Confusional state—Doxorubicin—prostate cancer	4.94e-05	0.000465	CcSEcCtD
Tetrabenazine—Headache—Docetaxel—prostate cancer	4.92e-05	0.000463	CcSEcCtD
Tetrabenazine—Asthenia—Prednisone—prostate cancer	4.86e-05	0.000457	CcSEcCtD
Tetrabenazine—Vomiting—Capecitabine—prostate cancer	4.84e-05	0.000455	CcSEcCtD
Tetrabenazine—Nervous system disorder—Doxorubicin—prostate cancer	4.81e-05	0.000452	CcSEcCtD
Tetrabenazine—Insomnia—Epirubicin—prostate cancer	4.79e-05	0.000451	CcSEcCtD
Tetrabenazine—Headache—Capecitabine—prostate cancer	4.77e-05	0.000448	CcSEcCtD
Tetrabenazine—Skin disorder—Doxorubicin—prostate cancer	4.76e-05	0.000448	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Doxorubicin—prostate cancer	4.74e-05	0.000446	CcSEcCtD
Tetrabenazine—Dyspnoea—Epirubicin—prostate cancer	4.72e-05	0.000444	CcSEcCtD
Tetrabenazine—Somnolence—Epirubicin—prostate cancer	4.71e-05	0.000443	CcSEcCtD
Tetrabenazine—Nausea—Docetaxel—prostate cancer	4.67e-05	0.000439	CcSEcCtD
Tetrabenazine—Diarrhoea—Prednisone—prostate cancer	4.64e-05	0.000436	CcSEcCtD
Tetrabenazine—Decreased appetite—Epirubicin—prostate cancer	4.61e-05	0.000433	CcSEcCtD
Tetrabenazine—Hypotension—Doxorubicin—prostate cancer	4.58e-05	0.000431	CcSEcCtD
Tetrabenazine—Fatigue—Epirubicin—prostate cancer	4.57e-05	0.00043	CcSEcCtD
Tetrabenazine—Constipation—Epirubicin—prostate cancer	4.53e-05	0.000426	CcSEcCtD
Tetrabenazine—Nausea—Capecitabine—prostate cancer	4.52e-05	0.000425	CcSEcCtD
Tetrabenazine—Dizziness—Prednisone—prostate cancer	4.48e-05	0.000422	CcSEcCtD
Tetrabenazine—Insomnia—Doxorubicin—prostate cancer	4.43e-05	0.000417	CcSEcCtD
Tetrabenazine—Dyspnoea—Doxorubicin—prostate cancer	4.37e-05	0.000411	CcSEcCtD
Tetrabenazine—Feeling abnormal—Epirubicin—prostate cancer	4.37e-05	0.000411	CcSEcCtD
Tetrabenazine—Somnolence—Doxorubicin—prostate cancer	4.36e-05	0.00041	CcSEcCtD
Tetrabenazine—Vomiting—Prednisone—prostate cancer	4.31e-05	0.000405	CcSEcCtD
Tetrabenazine—Decreased appetite—Doxorubicin—prostate cancer	4.26e-05	0.000401	CcSEcCtD
Tetrabenazine—Headache—Prednisone—prostate cancer	4.24e-05	0.000399	CcSEcCtD
Tetrabenazine—Fatigue—Doxorubicin—prostate cancer	4.23e-05	0.000398	CcSEcCtD
Tetrabenazine—Constipation—Doxorubicin—prostate cancer	4.19e-05	0.000394	CcSEcCtD
Tetrabenazine—Body temperature increased—Epirubicin—prostate cancer	4.19e-05	0.000394	CcSEcCtD
Tetrabenazine—Feeling abnormal—Doxorubicin—prostate cancer	4.04e-05	0.00038	CcSEcCtD
Tetrabenazine—Nausea—Prednisone—prostate cancer	4.02e-05	0.000379	CcSEcCtD
Tetrabenazine—Body temperature increased—Doxorubicin—prostate cancer	3.88e-05	0.000365	CcSEcCtD
Tetrabenazine—Asthenia—Epirubicin—prostate cancer	3.8e-05	0.000358	CcSEcCtD
Tetrabenazine—Diarrhoea—Epirubicin—prostate cancer	3.63e-05	0.000341	CcSEcCtD
Tetrabenazine—Asthenia—Doxorubicin—prostate cancer	3.52e-05	0.000331	CcSEcCtD
Tetrabenazine—Dizziness—Epirubicin—prostate cancer	3.5e-05	0.00033	CcSEcCtD
Tetrabenazine—Vomiting—Epirubicin—prostate cancer	3.37e-05	0.000317	CcSEcCtD
Tetrabenazine—Diarrhoea—Doxorubicin—prostate cancer	3.35e-05	0.000316	CcSEcCtD
Tetrabenazine—Headache—Epirubicin—prostate cancer	3.32e-05	0.000312	CcSEcCtD
Tetrabenazine—Dizziness—Doxorubicin—prostate cancer	3.24e-05	0.000305	CcSEcCtD
Tetrabenazine—Nausea—Epirubicin—prostate cancer	3.15e-05	0.000296	CcSEcCtD
Tetrabenazine—Vomiting—Doxorubicin—prostate cancer	3.12e-05	0.000293	CcSEcCtD
Tetrabenazine—Headache—Doxorubicin—prostate cancer	3.07e-05	0.000289	CcSEcCtD
Tetrabenazine—Nausea—Doxorubicin—prostate cancer	2.91e-05	0.000274	CcSEcCtD
Tetrabenazine—DRD2—Signaling Pathways—GRPR—prostate cancer	1.74e-05	0.00026	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CX3CL1—prostate cancer	1.72e-05	0.000258	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL17RD—prostate cancer	1.68e-05	0.000251	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PDE4D—prostate cancer	1.68e-05	0.000251	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GRHL1—prostate cancer	1.66e-05	0.000249	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TST—prostate cancer	1.66e-05	0.000249	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CSAD—prostate cancer	1.66e-05	0.000249	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PSAT1—prostate cancer	1.66e-05	0.000249	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ADI1—prostate cancer	1.66e-05	0.000249	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CBR1—prostate cancer	1.66e-05	0.000249	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CB—prostate cancer	1.63e-05	0.000244	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PTEN—prostate cancer	1.62e-05	0.000243	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTGS2—prostate cancer	1.62e-05	0.000242	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GNG5—prostate cancer	1.6e-05	0.000238	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—CXCL8—prostate cancer	1.59e-05	0.000238	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—EP300—prostate cancer	1.55e-05	0.000231	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UGT2B17—prostate cancer	1.55e-05	0.000231	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CKMT2—prostate cancer	1.55e-05	0.000231	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UGT2B15—prostate cancer	1.55e-05	0.000231	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GRHPR—prostate cancer	1.55e-05	0.000231	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PTHLH—prostate cancer	1.53e-05	0.000229	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JUP—prostate cancer	1.5e-05	0.000224	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—WNT4—prostate cancer	1.5e-05	0.000224	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—RFK—prostate cancer	1.45e-05	0.000217	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AOX1—prostate cancer	1.45e-05	0.000217	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SULT2B1—prostate cancer	1.45e-05	0.000217	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM3—prostate cancer	1.45e-05	0.000217	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NAGLU—prostate cancer	1.45e-05	0.000217	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PGAM2—prostate cancer	1.45e-05	0.000217	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MBTPS1—prostate cancer	1.45e-05	0.000217	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ANXA1—prostate cancer	1.44e-05	0.000215	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MC2R—prostate cancer	1.43e-05	0.000214	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RALBP1—prostate cancer	1.43e-05	0.000214	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTEN—prostate cancer	1.41e-05	0.000211	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PTHLH—prostate cancer	1.39e-05	0.000208	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AMACR—prostate cancer	1.38e-05	0.000206	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SRD5A2—prostate cancer	1.38e-05	0.000206	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NAT1—prostate cancer	1.38e-05	0.000206	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP3A43—prostate cancer	1.38e-05	0.000206	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—DEGS1—prostate cancer	1.38e-05	0.000206	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PRKACB—prostate cancer	1.36e-05	0.000203	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CALCA—prostate cancer	1.35e-05	0.000201	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—EP300—prostate cancer	1.35e-05	0.000201	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PPP3CA—prostate cancer	1.33e-05	0.000198	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCL12—prostate cancer	1.32e-05	0.000197	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSD17B1—prostate cancer	1.32e-05	0.000197	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ANXA1—prostate cancer	1.31e-05	0.000195	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PENK—prostate cancer	1.27e-05	0.00019	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	1.27e-05	0.000189	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CALCA—prostate cancer	1.22e-05	0.000183	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GHR—prostate cancer	1.22e-05	0.000182	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PRKCQ—prostate cancer	1.2e-05	0.000179	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCL12—prostate cancer	1.19e-05	0.000179	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—B4GALT4—prostate cancer	1.17e-05	0.000175	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HPGD—prostate cancer	1.17e-05	0.000175	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NRP1—prostate cancer	1.17e-05	0.000174	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADRB2—prostate cancer	1.13e-05	0.000169	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TP53—prostate cancer	1.11e-05	0.000166	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TNFRSF21—prostate cancer	1.1e-05	0.000165	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—VAV3—prostate cancer	1.1e-05	0.000164	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PRKCQ—prostate cancer	1.09e-05	0.000163	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VIP—prostate cancer	1.08e-05	0.000162	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GNRH1—prostate cancer	1.08e-05	0.000162	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP7B1—prostate cancer	1.07e-05	0.00016	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTAP—prostate cancer	1.07e-05	0.00016	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ITPR1—prostate cancer	1.07e-05	0.00016	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRP—prostate cancer	1.05e-05	0.000157	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LPAR1—prostate cancer	1.05e-05	0.000157	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SULT1E1—prostate cancer	1.05e-05	0.000156	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SRD5A1—prostate cancer	1.05e-05	0.000156	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LRP2—prostate cancer	1.04e-05	0.000155	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PLCB2—prostate cancer	1.04e-05	0.000155	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADRB2—prostate cancer	1.03e-05	0.000153	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CX3CL1—prostate cancer	1.02e-05	0.000152	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—P4HB—prostate cancer	1.02e-05	0.000152	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—IL6—prostate cancer	1.01e-05	0.000152	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—VAV3—prostate cancer	1e-05	0.000149	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HIST1H2BG—prostate cancer	1e-05	0.000149	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ACSL4—prostate cancer	9.97e-06	0.000149	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSD17B3—prostate cancer	9.97e-06	0.000149	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CA—prostate cancer	9.96e-06	0.000149	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRB7—prostate cancer	9.91e-06	0.000148	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDE4D—prostate cancer	9.91e-06	0.000148	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ITPR1—prostate cancer	9.7e-06	0.000145	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HIST1H4H—prostate cancer	9.65e-06	0.000144	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CXCL8—prostate cancer	9.65e-06	0.000144	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ARG2—prostate cancer	9.56e-06	0.000143	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UMPS—prostate cancer	9.56e-06	0.000143	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PHGDH—prostate cancer	9.56e-06	0.000143	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GNG5—prostate cancer	9.42e-06	0.000141	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—LDHB—prostate cancer	9.37e-06	0.00014	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP3A5—prostate cancer	9.2e-06	0.000137	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TCN2—prostate cancer	8.89e-06	0.000133	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PDHA1—prostate cancer	8.89e-06	0.000133	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA3—prostate cancer	8.89e-06	0.000133	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UCP3—prostate cancer	8.89e-06	0.000133	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC22A3—prostate cancer	8.48e-06	0.000127	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSD3B1—prostate cancer	8.48e-06	0.000127	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFBR1—prostate cancer	8.21e-06	0.000123	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTHLH—prostate cancer	8.21e-06	0.000123	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKT1—prostate cancer	8.13e-06	0.000122	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TBXAS1—prostate cancer	8.13e-06	0.000121	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA4—prostate cancer	8.13e-06	0.000121	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKR1C3—prostate cancer	8.08e-06	0.000121	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRKACB—prostate cancer	8.03e-06	0.00012	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA2—prostate cancer	7.92e-06	0.000118	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—THBS1—prostate cancer	7.83e-06	0.000117	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PPP3CA—prostate cancer	7.83e-06	0.000117	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SULT1A1—prostate cancer	7.82e-06	0.000117	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCG5—prostate cancer	7.82e-06	0.000117	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ANXA1—prostate cancer	7.72e-06	0.000115	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA1—prostate cancer	7.64e-06	0.000114	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRKCZ—prostate cancer	7.58e-06	0.000113	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSD3B2—prostate cancer	7.56e-06	0.000113	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTO1—prostate cancer	7.56e-06	0.000113	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NAT2—prostate cancer	7.56e-06	0.000113	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CG—prostate cancer	7.4e-06	0.000111	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGFR4—prostate cancer	7.32e-06	0.000109	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PARP1—prostate cancer	7.32e-06	0.000109	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PLCB2—prostate cancer	7.24e-06	0.000108	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—LRP2—prostate cancer	7.24e-06	0.000108	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2C18—prostate cancer	7.24e-06	0.000108	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CALCA—prostate cancer	7.23e-06	0.000108	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—P4HB—prostate cancer	7.1e-06	0.000106	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL12—prostate cancer	7.06e-06	0.000105	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC22A1—prostate cancer	6.91e-06	0.000103	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SULT2A1—prostate cancer	6.73e-06	0.000101	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CG—prostate cancer	6.72e-06	0.0001	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CASP9—prostate cancer	6.65e-06	9.93e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MED12—prostate cancer	6.63e-06	9.9e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GNG5—prostate cancer	6.57e-06	9.82e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CD—prostate cancer	6.51e-06	9.73e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NGFR—prostate cancer	6.44e-06	9.62e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRKCQ—prostate cancer	6.44e-06	9.62e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAP3K7—prostate cancer	6.36e-06	9.51e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOA3—prostate cancer	6.33e-06	9.46e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF10—prostate cancer	6.12e-06	9.14e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADRB2—prostate cancer	6.06e-06	9.05e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HPGDS—prostate cancer	6.04e-06	9.02e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2C19—prostate cancer	6e-06	8.97e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—JAK2—prostate cancer	5.97e-06	8.93e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MAP2K1—prostate cancer	5.95e-06	8.89e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CD—prostate cancer	5.91e-06	8.83e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VAV3—prostate cancer	5.91e-06	8.82e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ACHE—prostate cancer	5.86e-06	8.75e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTT1—prostate cancer	5.86e-06	8.75e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFBR2—prostate cancer	5.82e-06	8.7e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2A6—prostate cancer	5.79e-06	8.65e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ITPR1—prostate cancer	5.73e-06	8.56e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CB—prostate cancer	5.67e-06	8.48e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKR1C3—prostate cancer	5.63e-06	8.42e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PRKACB—prostate cancer	5.6e-06	8.37e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.55e-06	8.29e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1R—prostate cancer	5.48e-06	8.18e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCL8—prostate cancer	5.45e-06	8.15e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—JAK2—prostate cancer	5.42e-06	8.11e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOA2—prostate cancer	5.28e-06	7.9e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LPL—prostate cancer	5.25e-06	7.85e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IL2—prostate cancer	5.21e-06	7.79e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDGFRB—prostate cancer	5.2e-06	7.77e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CB—prostate cancer	5.15e-06	7.7e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ITGB3—prostate cancer	5.07e-06	7.58e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.04e-06	7.53e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCL8—prostate cancer	4.95e-06	7.4e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2E1—prostate cancer	4.92e-06	7.36e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB3—prostate cancer	4.92e-06	7.35e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGFR2—prostate cancer	4.91e-06	7.34e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NQO1—prostate cancer	4.87e-06	7.27e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TH—prostate cancer	4.8e-06	7.17e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP3A4—prostate cancer	4.75e-06	7.09e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL2—prostate cancer	4.73e-06	7.07e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TERT—prostate cancer	4.71e-06	7.04e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1B1—prostate cancer	4.67e-06	6.97e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GGT1—prostate cancer	4.52e-06	6.75e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HIF1A—prostate cancer	4.51e-06	6.74e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOA1—prostate cancer	4.45e-06	6.65e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LEP—prostate cancer	4.4e-06	6.58e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.39e-06	6.56e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CAV1—prostate cancer	4.36e-06	6.52e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KDR—prostate cancer	4.31e-06	6.44e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—RXRA—prostate cancer	4.24e-06	6.33e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ESR1—prostate cancer	4.2e-06	6.28e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—BAD—prostate cancer	4.1e-06	6.13e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—COMT—prostate cancer	4.08e-06	6.1e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTP1—prostate cancer	4.06e-06	6.07e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ITPR1—prostate cancer	4e-06	5.97e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CG—prostate cancer	3.97e-06	5.93e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APC—prostate cancer	3.97e-06	5.93e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGF—prostate cancer	3.93e-06	5.87e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IRS1—prostate cancer	3.93e-06	5.87e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GSK3B—prostate cancer	3.81e-06	5.69e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TYMS—prostate cancer	3.78e-06	5.64e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—INS—prostate cancer	3.76e-06	5.62e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM1—prostate cancer	3.73e-06	5.58e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CREBBP—prostate cancer	3.68e-06	5.5e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—LPL—prostate cancer	3.66e-06	5.47e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1—prostate cancer	3.64e-06	5.43e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EGFR—prostate cancer	3.62e-06	5.41e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.54e-06	5.29e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAP2K1—prostate cancer	3.52e-06	5.25e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ERCC2—prostate cancer	3.51e-06	5.24e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CD—prostate cancer	3.49e-06	5.22e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	3.46e-06	5.17e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SERPINE1—prostate cancer	3.45e-06	5.16e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—KRAS—prostate cancer	3.42e-06	5.11e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF2—prostate cancer	3.34e-06	5e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTHFR—prostate cancer	3.3e-06	4.93e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOS3—prostate cancer	3.3e-06	4.93e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPARA—prostate cancer	3.24e-06	4.83e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JAK2—prostate cancer	3.2e-06	4.79e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	3.14e-06	4.69e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MDM2—prostate cancer	3.13e-06	4.67e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB2—prostate cancer	3.08e-06	4.61e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CB—prostate cancer	3.04e-06	4.55e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CAV1—prostate cancer	3.04e-06	4.55e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL8—prostate cancer	2.92e-06	4.37e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1B—prostate cancer	2.86e-06	4.27e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT1—prostate cancer	2.83e-06	4.22e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CASP3—prostate cancer	2.8e-06	4.18e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL2—prostate cancer	2.8e-06	4.18e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6—prostate cancer	2.78e-06	4.16e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.77e-06	4.14e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCND1—prostate cancer	2.72e-06	4.07e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CTNNB1—prostate cancer	2.7e-06	4.03e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MMP9—prostate cancer	2.65e-06	3.95e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1A—prostate cancer	2.64e-06	3.94e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTEN—prostate cancer	2.63e-06	3.93e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—INS—prostate cancer	2.62e-06	3.92e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CREBBP—prostate cancer	2.57e-06	3.84e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT1—prostate cancer	2.57e-06	3.83e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EP300—prostate cancer	2.51e-06	3.75e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SRC—prostate cancer	2.44e-06	3.64e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.44e-06	3.64e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—prostate cancer	2.38e-06	3.55e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—STAT3—prostate cancer	2.35e-06	3.51e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NOS3—prostate cancer	2.3e-06	3.44e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MYC—prostate cancer	2.19e-06	3.27e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFB1—prostate cancer	2.18e-06	3.26e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGFR—prostate cancer	2.14e-06	3.19e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.12e-06	3.17e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTGS2—prostate cancer	2.1e-06	3.14e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KRAS—prostate cancer	2.02e-06	3.02e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.86e-06	2.77e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTEN—prostate cancer	1.83e-06	2.74e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TP53—prostate cancer	1.79e-06	2.68e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—EP300—prostate cancer	1.75e-06	2.61e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6—prostate cancer	1.64e-06	2.45e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT1—prostate cancer	1.52e-06	2.26e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.29e-06	1.93e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKT1—prostate cancer	1.06e-06	1.58e-05	CbGpPWpGaD
